Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Understanding their adverse event profiles helps healthcare providers make informed decisions about patient selection and monitoring requirements
Recaticimab add-on therapy in patients with non-familial hypercholesterolaemia and mixed hyperlipidemia (REMAIN-2)
American Diabetes Association 77th Scientific Sessions, San Diego, CA, June 913, 2017 (2017)
After several weeks of training for all study-related procedures, 70 out of 85 monkeys were selected based on blood chemistry and BW data collected at the end of the training period
Dose titration is the primary strategy recommended to minimise side effects
U S A 108, 1019010195
US$ 23.63
US$ 20.68
US$ 20.49
US$ 21.53
